JP Stock MarketDetailed Quotes

3349 COSMOS Pharmaceutical

Watchlist
  • 6934.0
  • -181.0-2.54%
20min DelayTrading Nov 7 10:12 JST
554.73BMarket Cap22.47P/E (Static)

COSMOS Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

COSMOS Pharmaceutical Q1 2025 Earnings Date

Currency：JPYOct 11, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
261.25B
261.84B
+589.48M
Beat Est.
+8.11%
+8.35%
+0.23%
EPS
88.69
102.74
+14.05
Beat Est.
+7.93%
+25.03%
+15.84%
Analyst Rating
Buy

Oct 24, 2024

COSMOS Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q3 -- / 258.169B --
Jan 10, 2025 2025/Q2 -- / 250.434B --
Oct 11, 2024 2025/Q1 261.841B / 261.252B --
Jul 12, 2024 2024/Q4 249.678B / 251.307B --
Apr 12, 2024 2024/Q3 238.881B / 234.831B --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 258.169B--
Jan 10, 20252025/Q2-- / 250.434B--
Oct 11, 20242025/Q1261.841B / 261.252B--
Jul 12, 20242024/Q4249.678B / 251.307B--
Apr 12, 20242024/Q3238.881B / 234.831B--

Unlock Free Earnings Estimates

COSMOS Pharmaceutical Earnings Reports

  • COSMOS Pharmaceutical: Summary of Financial Results for the 1st Quarter Ending May 2025 [Japanese GAAP] (Consolidated)

    Oct 11 14:00

  • COSMOS Pharmaceutical: Extraordinary Report

    Aug 30 13:37

  • COSMOS Pharmaceutical: Confirmation letter

    Aug 29 15:21

  • COSMOS Pharmaceutical: Financial Report - 42nd Term (2023/06/01 - 2024/05/31)

    Aug 29 15:20

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 24, 2024

    Buy

    • Strong Buy

      30.77%

    • Buy

      15.39%

    • Hold

      53.85%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data